Join us to gain practical experience in pharmaceutical Market Access while contributing to a data-driven assessment of how innovation in multiple myeloma has changed patient outcomes and medicine costs in Switzerland.
Position Overview - Tasks & Responsibilities
As an intern in our Market Access team, you will support a strategic project examining how medicine costs and patient outcomes have evolved in multiple myeloma (MM) in Switzerland. Working closely with experienced colleagues, you will help place these developments in historical context and benchmark MM against other oncological diseases. Your tasks will include:
Map the evolution of PFS outcomes in MM over time and relate these outcomes to medicine costs by year of approval, including costs per PFS month.
Present cost developments as indexed levels and changes versus a defined baseline year, without disclosing confidential individual prices.
Estimate the PFS gain associated with individual therapies and treatment lines.
Compare PFS outcomes and cost-effectiveness trends in MM with selected other oncological diseases.
Analyse MM prevalence and, where feasible, incidence over time and relate patient numbers to total medicine expenditure in the Swiss MM market.
Derive annual medicine cost per patient and the number of patients by budget year.
Assess the historical evolution of overall survival (OS) and PFS in first-line MM treatment, comparing current outcomes with those from approximately 15 years ago.
Compare total medicine expenditure in MM with selected other oncological diseases.
Build the evidence base using published studies and other appropriate sources for PFS and OS data, and develop a robust approach using indexed values where concrete prices cannot be used.
Align the analytical approach and any use of confidential data with relevant Compliance requirements.
Qualifications - Education and Experience
Ongoing or recently completed bachelor's or master's degree in health economics, economics, epidemiology, public health, pharmacy, medicine, life sciences, data science or a related discipline.
Strong interest in oncology, pharmaceutical market access and the Swiss healthcare system.
Experience with quantitative research, literature review and the interpretation of clinical outcomes such as PFS and OS is an advantage.
Qualifications - Skills
Strong analytical skills and confidence working with complex clinical, epidemiological and cost data.
Very good command of Microsoft Excel; experience with R, Python or another statistical tool is an advantage.
Ability to translate scientific and economic evidence into a clear, practical narrative.
Very good English skills; German skills are an advantage.
High level of initiative, accuracy, discretion and ability to work independently and collaboratively.
Our Offering
A 6-month, full-time internship in an international healthcare company, with the start date agreed with the successful candidate.
Hands-on experience with a strategically relevant project at the intersection of oncology, health economics and market access.
Close collaboration with experienced Market Access colleagues, regular guidance and opportunities to contribute to a high-impact analytical project.
Flexible working conditions, including the opportunity for up to 40% remote work where the role and applicable policies allow.
Please mention in your application if you learned about this opportunity through the Health Science Club.
Required Skills
Preferred Skills